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Thyroxine Is the Serum Factor That Regulates 
Morphogenesis of Columnar Cartilage from Isolated 
Chondrocytes m Chelmeally Defined Medium 
R. Tracy Ballock, and A. H. Reddi 
Laboratory of Musculoskeletal Cell Biology, Department ofOrthopaedic Surgery, The Johns Hopkins University 
School of Medicine, Baltimore, Maryland 21205 
Abstract. Epiphyseal chondrocytes cultured in a 
medium containing 10% serum may be maintained as 
three dimensional aggregates and differentiate t rmi- 
nally into hypertrophic cells. There is an attendant ex- 
pression of genes encoding type X collagen and high 
levels of alkaline phosphatase activity. Manipulation of 
the serum concentration to optimal evels of 0.1 or 
0.01% in this chondrocyte pellet culture system results 
in formation of features of developing cartilage ar- 
chitecture which have been observed exclusively in 
growth cartilage in vivo. Cells are arranged in 
columns radiating out from the center of the tissue, 
and can be divided into distinct zones corresponding 
to the recognized stages of chondrocyte differentiation. 
Elimination of the optimal serum concentration i a 
chemically defined medium containing insulin 
eliminates the events of terminal differentiation of de- 
freed cartilage architecture. Chondrocytes continue to 
enlarge into hypertrophic cells and synthesize type X 
collagen mRNA and protein, but in the absence of the 
optimal serum concentration, alkaline phosphatase ac- 
tivity does not increase and the cells retain a random 
orientation. Addition of thyroxine to the chemically 
defined medium containing insulin and growth hor- 
mone results in dose-dependent i creases in both type 
X collagen synthesis and alkaline phosphatase activity, 
and reproduces the optimal serum-induced morpho- 
genesis of chondrocytes into a columnar pattern. 
These experiments demonstrate he critical role of 
thyroxine in cartilage morphogenesis. 
T 
ERMINAL differentiation of chondrocytes into hy- 
pertrophic ells is an obligatory step in the endo- 
chondral ossification pathway that occurs during em- 
bryonic bone development, longitudinal bone growth, and 
fracture healing. This terminal differentiation process is 
marked by a several-fold increase in cell volume (11), syn- 
thesis of type X collagen, and high" levels of alkaline phos- 
phatase activity. The net result of this developmental process 
is an increase in length of the growing bone and the mineral- 
ization of the surrounding cartilage matrix. This mineralized 
extracellular matrix of cartilage provides the scaffold for the 
deposition of new bone matrix by invading osteoblasts. 
The identification of factors regulating this critical de- 
velopmental pathway of the skeleton has been hampered by 
lack of a suitable in vitro model. It is well-established that 
chondrocytes lose their polygonal morphology and dedif- 
ferentiate when placed in traditional monolayer cultures 
in vitro on tissue culture plastic, a problem which is exacer- 
bated by low cell density or multiple passages (4-6, 25). Al- 
though suspending chondrocytes in culture media or agarose 
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stabilizes the chondrocyte phenotype and permits terminal 
differentiation i to hypertrophic ells (3, 6, 25), the lack of 
a three-dimensional tissue architecture prevents morphogen- 
esis of growing cartilage and its study as an organized tissue. 
We have resolved this dilemma by modification of a simple 
method of chondrocyte culture which maintains cells as an 
aggregated cell pellet, thereby more closely approximating 
the three-dimensional environment of developing cartilage in 
vivo under strict control of culture conditions (13). Although 
this aggregation ofcells is not distinguished immediately fol- 
lowing centrifugation, after 21 days in culture asizeable car- 
tilage nodule develops (Fig. 1). When cultured in medium 
containing 10% serum, chondrocytes maintained as cell pel- 
lets terminally differentiate into hypertrophic cells, express 
genes encoding type X collagen, and exhibit high levels of 
alkaline phosphatase activity, all of which can be reversibly 
inhibited by exogenous addition of TGF-/~I (2). 
The potential utility of this model to investigate vents 
linked to chondrocyte differentiation is limited due to the 
presence of serum and precludes the identification of specific 
factors responsible for the regulation of key steps of this se- 
quential differentiation process. We and others have there- 
fore attempted toestablish culture conditions which will al- 
low chondrocyte differentiation to proceed in chemically 
defined media (7, 19, 23). The present investigation demon- 
© The Rockefeller University Press, 0021-9525/94/09/1311/8 $2.00 
The Journal of Cell Biology, Volume 126, Number 5, September 1994 1311-1318 1311 
Figure 1. Gross appearance of chondrocyte cell pellet after 21 days 
of culture in chemically defined DME:FI2 medium supplemented 
with insulin (5 #g/ml). The original cell pellet at the beginning 
of the culture period was barely visible on gross inspection. Bar, 
lmm.  
strates that optimization of the serum concentration to 0ol or 
0.01% in this three-dimensional culture system results in 
morphogenesis of developing cartilage architecture which 
have been observed previously only in growth cartilage in 
vivo. Cells are arranged in columns radiating out from the 
center of the tissue, and can be divided into distinct zones 
corresponding to the recognized stages of chondrocyte dif- 
ferentiation. Elimination of serum in this chemically defined 
medium containing insulin as the sole regulatory factor re- 
sults in the blockade of terminal differentiation. Although 
chondrocytes continue to enlarge into hypertrophic cells and 
synthesize type X collagen mRNA and protein, in the ab- 
sence of serum alkaline phosphatase activity does not in- 
crease and the cells retain a random orientation. Addition of 
thyroxine to chemically defined medium containing insulin 
and growth hormone, however, results in a dose-dependent 
increase in both type X collagen synthesis and alkaline phos- 
phatase activity, and morphogenesis of chondrocytes into a 
columnar pattern reminiscent of the in vivo growth plate. 
Materials and Methods 
Materials 
Fitton-Jackson modified BGFo medium, CMRL 1066 medium, DME, a 
combination fDME: Ham's F12 medium (1:1), MEM, Ham's F12 medium, 
penicillin-streptomycin, PBS, sodium pyruvate, FBS, and recombinant hu- 
man insulin-like growth factor I and H (IGF-I and IGF-II) (all from GIBCO, 
Grand Island, NY); Collagcoase P and purified bacterial collagenase (Boeh- 
ringer Mannheim, Indianapolis, IN); L-ascorbic acid phosphate (Wako 
Biochemicals, Richmond, VA); ITS + Premix (Collaborative Research, 
Bedford, MA); L-thyroxine, beta-aminopmprionitrile (BAPN) I, pepsin, 
p-nilmphenol phosphate, and Folin's reagent (all from Sigma Chemical Co., 
St. Louis, MO); [32p]dCTP and [U-14C]-proline (Amersham International, 
Amersham, UK); EN3HANCE (New England Nuclear, Boston, MA); rat 
growth hormone was a gift from the National Hormone and Pituitary Pro- 
gram (National Institute of Arthritis, Diabetes, and Digestive and Kidney 
Diseases and National Institutes of Health, Bethesda, MD); recombinant 
porcine TGF-~I was a gift from Michael Sporn and Anita Roberts (National 
Cancer Institute, and National Institutes of Health, Bethesda, MD); bone 
morphogenetic protein-3 (BMP-3) was purified from demineralized bovine 
matrix as previously described (17, 24); recombinant human BMP-4 was a 
gift from Dr. Glenn Hamrnonds (Genentech, South San Francisco, CA); 
recombinant human OP-1 (BMP-7) was a gift from T. Kuber Sampath (Crea- 
tive Biomolecules, Hopkinton, MA). 
Chondrocyte Isolation 
Chondrocytes were isolated from the resting zone of the distal femoral 
growth cartilage of two-d-old neonatal Sprague-Dawley rats by collagenaso 
digestion. The distal femora were exposed by dissection u der loupe mag- 
nification. Adherent soft tissues were stripped away nd the reserve zone 
of the epiphysis removed by dissection. The cartilage fragments containing 
the reserve zone cbondrocytes were washed three times in PBS containing 
1% penicillin/streptomycin anddigested for 4 h in a 0.3 % solution of Col- 
lagenase P in PBS in a shaking water bath at 37°C. The solution containing 
the isolated cells was filtered through 70-# mesh and the cells recovered by 
centrifugation at 1D00 rpm at 4°C and resuspended in culture medium at 
a final concentration f 160,000 cells/ml. 
Three-dimensional Pe let Culture 
Chondrocytes were cultured as a three-dimensional cell p llet as previously 
described (2). Briefly, 1-ml allquots containing 160,000 cells each were 
added to 15-ml conical polypropylene c ntrifuge tubes and the cells pelleted 
by centrifugation at 1,000 rpm for 5 min at 4°C. The cultures were then 
maintained at37°C in 95% oxygen and 5% CO2 in a humidified incubator. 
Medium was changed every other day after the third day. 
Pellets were maintained up to 21 days in DME:F12 medium sup- 
plemented with 50/~g/ml L-ascorbic acid phosphate (10), 100 #g/ml sodium 
pyruvate, 1% (vol/vol) penicillin-streptomycin, andeither heat-inaetivated 
FBS or a defined media supplement yielding a final concentration f 6.25 
#g/mi bovine insulin, 6.25 #g/ml transferrin, 6.25 ng/mi selenous acid, 1.25 
mg/mi bovine serum albumin, and 5.35 #g/ml linoleic acid. To study the 
effect of the composition of the chemically defined media on chondrocyte 
differentiation, pellets were also maintained in the following five culture 
media supplemented as described above: Fitton-Jackson modified BGJb me- 
dium; CMRL 1066 medium; Ham's FI2 medium; DME alone; and MEM. 
In some experiments, the following factors were substituted one at a time 
for insulin and/or added to insulin-containing media for the entire 21-d cul- 
ture period: recombinant human IGF-I (20 ng/mi); recombinant buman 
IGF-II (20 ng/mi); bovine insulin (100 ng/ml); rat growth hormone (50 
ng/ml); recombinant porcine TGF-/~I (10 ng/mi); L-thyroxine (1-100 ng/ml); 
purified bovine BMP-3 (10 ng/mi); recombinant human BMP-4 (10 ng/ml); 
recombinant human BMP-7 (10 ng/mi); and BAPN (100 #g/ml). These fac- 
tors were re-added with each change of the culture medium. 
Tissue Morphology 
Pellets were fixed in 10% neutral buffered formalin, dehydrated through 
graded alcohols, and embedded in glycol methacrylate. 3-# sections per- 
pendicular to the short axis of the pellets were cut on a glass knife and 
stained with toluldine blue for light microscopy. 
Northern Blotting 
20-30 pooled samples per group were snap frozen and total cellular RNA 
extracted by homogenization in 6 M guanidine HCI, followed by cesium 
chloride gradient centrifugation a d sequential lithium chloride and lithium 
chloride/ethanol precipitation. 5 t~l of total cellular RNA per lane were 
1. Abbreviations used in this paper: BAPN, beta-aminoproprionitrile; BMP,
bone morphogenetic protein; GAPDH, glyceraldehyde phosphate dehy- 
drogenase. 
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separated by electrophoresis through 1% agarose gels. The separated RNA 
was transferred to nylon membranes and crosslinked to the filter by ex- 
posure to ultraviolet light. Radiolabeling of cDNA probes with [32p]dCTP 
was performed using the random priming technique. Membranes ware pre- 
hybridized, hybridized, and washed by the method of Church and Gilbert 
(8), and exposed to radiographic film at -70°C using intensifying screens. 
To examine the endogenous expression of BMP genes in intact growth 
cartilage, total cellular RNA was extracted from the entire growth cartilage 
of pooled istal femoral epiphyses obtained from 2-d-old neonatal Sprague- 
Dawley rats by the above method. 
cDNA Probes 
The following cDNA sequences were used to examine gene expression by 
Northern hybridization: pRC2, encoding 600 bp of the amino terminus of 
the rat alpha I(II) collagen gene (14); pSAMI0h, encoding 600 bp of exon 
3 and the 3' untranslated region of the mouse type X collagen gene (1); 
and a Pstl fragment of the rat glyceraldehyde phosphate dehydrogenase 
(GAPDH) cDNA for assessment of equivalence of RNA loading. 
Collagen Labeling and Extraction 
Cultures were treated with 100 #g/rul of BAPN for 20 rain before labeling 
with 5 #Ci/ml of [U-14C]-proline for the final 48 h of the culture period. 
Labeled collagens were extracted according to previously published meth- 
ods (6, 12). Briefly, labeled pellets were homogenized in 0.5 N acetic 
acid and digested with 1 mg/ml pepsin in 0.5 N acetic acid for 24 h at 4°C 
before inactivation of the pepsin by the addition of Tris to 50 mM and titra- 
tion to neutral pH with concentrated NaOH using phenol red as an indica- 
tor. Pepsin-resistant material was extracted for an additional 24 h in 0.15 M 
NaCI containing 20 mM DTT and 50 mM Tris-HC1 at pH 7.4 in the pres- 
ence of protease inhibitors (5 mM EITrA, 1 mM PMSF, 1 mM PABA, and 
5 mM NEM). Pepsin digests and DTT extracts ware combined and concen- 
trated in a Centricon-30 concentrator with a molecular weight cutoff of 
30000. Aliquots of labeled collagen (10,000 cpm per sample) were analyzed 
by SDS/PAGE on 4-20% gradient gels under educing conditions. Some 
samples were digested with 2.5 units of purified bacterial collagenase for 
1 h at 37°C prior to gel electrophoresis. Gels ware processed for fluorogra- 
phy with EN3HANCE and exposed to radiographic film at -70°C. 
To examine collagen synthesis n explant cultures of intact growth carti- 
lage, the hypertrophic zones of both the distal femoral ephiphyses of2-d-old 
neonatal rats ware'removed and cultured for 3 d in DME:F12 medium con- 
taining 10% FBS. Collagens were then labeled and extracted exactly as de- 
scribed above. 
Alkaline Phosphatase Activity 
Pellets were homogenized in 2 ml of ice-cold 0.15 M NaCI containing 3 mM 
NaHCO3 (pH 7.4) with three 10-s bursts using a Polytron homogenizer and 
centrifuged at 20,000 g for 30 min at 4°C. The supernatants ware assayed 
for alkaline phosphatase activity in 0.1 M sodium barbital buffer (pH 9.3) 
using p-nitrophenyl phosphate as a substrate as previously described (21). 
The amount of protein contained in the enzyme xtracts was determined 
(16), and the enzyme activity expressed as units of alkaline phosphatase ac- 
tivity per mg protein. 1 unit of alkaline phosphatase was defined as the en- 
zyme activity that liberated 1 #mol p-nitrophenol/30 rain at 37°C per mg 
protein. 
Statistical Analysis 
One-way analysis of variance (ANOVA) was used to assess the effect of the 
measured variables on alkaline phosphatase activity. Statistical significance 
between pairs of means within a group was determined by multiple t tests 
after adjusting the significance l vel for multiple comparisons by the Bon- 
ferroni method. 
Results 
Reducing the Serum Concentration i
the Media Facilitates Morphogenesis of Columnar 
Cartilage Architecture 
Chondrocytes cultured in DME:F12 medium supplemented 
with 10 % serum acquired ahypertrophic morphology by day. 
21 of the culture period, as previously demonstrated (2) (Fig. 
2 a). It is noteworthy that perichondrium-like layer of fiat- 
tened proliferating cells surrounded the tissue. Cells cul- 
tured in DME:F12 containing insulin in place of serum also 
acquired ahypertrophic morphology by day 21, but in the ab- 
sence of serum, no perichondrium-like layer of cells formed 
on the outside of the pellet (Fig. 2 f ) .  
To determine the minimal concentration of serum which 
would support full terminal differentiation of chondrocytes 
in vitro, cells were cultured in DME:F12 with serum concen- 
trations of less than 10%. Surprisingly, histologic analysis 
of pellets maintained for 21 d in minimal serum concentra- 
tions of 0.1 or 0.01% revealed that chondrocytes became or- 
ganized in a columnar pattern, with the columns of cells 
radiating outward from the center of the pellet (Fig. 2, c and 
d). This columnar architecture remarkably resembled the 
appearance ofdeveloping rowth plate cartilage in vivo. The 
columns consisted of at least two discrete zones of differen- 
tiating cells, with the hypertrophic zone located on the inner 
aspect of the pellet and the proliferative zone located in the 
middle region. This columnar architecture produced by cul- 
turing cells under optimal serum conditions was disrupted 
by withholding ascorbic acid from the medium (Fig. 2 e), 
or by inhibiting collagen crosslinking by addition of beta- 
aminoproprionitrile (Fig. 2 g). 
In the pellets maintained in 10% serum, an envelope of 
flattened perichondrium-like c lls ~3-5 cells thick was ob- 
served around the exterior of the pellet (Fig. 2 a). As the se- 
rum concentration decreased to 1%, the thickness of this 
perichondrium-like layer decreased to 2-3 cell layers (Fig. 
2 b). At serum concentrations of 0.1 and 0.01%, this flattened 
layer of cells could no longer be identified (Fig. 2, c and d). 
Type X collagen gene expression was detectable by day 14 
and persisted through day 21 in 10% serum-treated cultures 
(Fig. 3). In cultures maintained in chemically defined media 
containing insulin in place of serum, type X collagen gene 
expression was present as early as day 14, but did not reach 
levels comparable to 10% serum-treated specimens until day 
21. Reducing the serum concentration modestly increased 
the level of type X collagen gene expression by day 21 of the 
culture period (Fig. 4). 
Synthesis of type X collagen protein in the presence of 
10% serum was also apparent by day 14, but was only faintly 
detectable by day 21 (Fig. 5, lane 5). The ratio of type X col- 
lagen to type II collagen protein was increased in the insulin- 
treated cells compared to the 10% serum-treated cells by day 
21 (Fig. 5, lanes 1 and 5). Reducing the serum concentration 
appeared to increase the level of type X collagen protein syn- 
thesized by the cells at day 21 (Fig. 5~ lanes 1-5). 
Alkaline phosphatase activity increased significantly in 
10% serum-treated cultures compared to insulin-treated 
controls by day 14 (p < 0.01), and remained significantly 
elevated over controls by day 21 (/7 < 0.001) (Fig. 6). Alkaline 
phosphatase activity reached maximum levels in cultures 
treated with 10% serum, decreased moderately as the serum 
concentration was reduced to 0.01%, then fell precipitously 
as serum was completely removed and replaced with insulin 
(Fig. 7). 
One-way analysis of variance (ANOVA) confirmed a sig- 
nificant effect of serum concentration on resulting alkaline 
phosphatase activity (17 < 0.001). Pairwise comparisions of 
means confirmed that he insulin-treated group exhibited sig- 
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l~gure 2. Morphologic appear- 
ance of chondroeytes main- 
tained in pellet cultures for 21 
days in DME:F12 media sup- 
plemented with decreasing 
concentrations of serum: (A) 
10% FBS; (B) 1% FBS; (C) 
0.1% FBS; (D) 0.01% FBS; (E) 
0.1% FBS minus L-ascorbic 
acid phosphate; (F) insulin 
alone (5 #g/ml); (G) 0.1% ser- 
um plus beta-aminoproprioni- 
trile (100 ng/ml); (H) insulin 
(5 #g/lad) minus L-ascorbic 
acid phosphate. The arrow- 
heads in A and B identify the 
perichondrium-like layer of 
cells surrounding the cell pel- 
let. Bar, 100 #m. 
nificantly less alkaline phosphatase activity at day 21 than all 
other serum-treated specimens (p < 0.01). 
Thyroxine Is the Serum Factor That Regulates 
Morphogenesis of Columnar Cartilage 
Addition of rat growth hormone (50 ng/ml) to insulin-con- 
taming media inhibited ifferentiation f these cells into hy- 
pertrophic chondrocytes and did not alter the random orien- 
tation of cells previously observed in the absence of serum 
(Fig. 8 a). Growth hormone treatment also did not result in 
a noticeable increase in pellet size, type X collagen syn- 
thesis, or alkaline phosphatase activity compared to insulin- 
containing medium alone. When thyroxine was added to 
chemically defined media containing rowth hormone and 
insulin, however, the inhibitory effect of growth ormone on 
chondrocyte hypertrophy was reversed. At a concentration f 
100 ng/ml, thyroxine administration reproduced th  serum- 
induced organization ofchondrocytes into longitudinal col- 
umns (Fig. 8 b). Likewise, thyroxine tfected ose-respon- 
sive increases in both type X collagen synthesis (Fig. 5, lanes 
10-12) and alkaline phosphatase activity (Fig. 9). One-way 
ANOVA confirmed that hyroxine concentration significantly 
increased resulting alkaline phosphatase activity (p < 0.001). 
Chondrocyte Hypertrophy in the Absence of Serum Is 
Dependent on the Formulation of the Culture Media 
The acquisition of the hypertrophic morphology by chon- 
drocytes cultured in insulin-supplemented medium was de- 
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Figure 3. A. Expression of genes encoding type II collagen and type 
X collagen by chondrocytes in pellet cultures maintained for 7, 14, 
and 21 days in the presence of 10% FBS or insulin (5 #g/ml). 
pendent on the formulation of the culture medium used. Only 
cells cultured in DME or a 1:1 combination ofDME:F12 me- 
dium demonstrated widespread morphologic evidence of hy- 
pertrophy (Fig. 10, c and d). Cells cultured in insulin-con- 
taining Fitton-Jackson modified BGJb medium, CMRL 
1066 medium, MEM, and Ham's F12 medium did not show 
consistent morphologic evidence of cellular hypertrophy 
(Fig. 10, a, b, e, and f ) .  
Similarly, only cells cultured in DME:F12 or DME alone 
displayed evidence of type X collagen gene expression by day 
21 (Fig. 11). Unexpectedly, this level of type X gene expres- 
sion was noticeably greater in DME:F12 medium than DME 
alone. Ceils cultured in insulin-containing Fitton-Jackson 
modified BGJb medium, CMRL 1066 medium, MEM, and 
Ham's F12 medium demonstrated no type X collagen gene 
expression by day 21, even on overexposed autoradiographs. 
Although alkaline phosphatase activity was significantly 
elevated in DME or DME:F12 medium compared to the 
other formulations (p < 0.001) (Fig. 12), this activity re- 
mained at essentially baseline levels compared to serum- 
treated or thyroxine-treated cultures. 
Insulin/IGF Is Required for Continued 
Chondrocyte Survival, but Does Not Stimulate 
Terminal Differentiation 
In the absence of serum, replacement of insulin with recom- 
Figure 5. SDS/PAGE (4-20% gradient gel) analysis of [14C]- 
proline-labeled proteins extracted from chondroeyte pellets as de- 
scribed under Materials and Methods. Unless otherwise indicated, 
all cultures were maintained for 21 days in DME:F12 medium sup- 
plemented with L-aseorbic acid phosphate (50 /~g/ml), sodium 
pyruvate (100 ttg/ml) and the following components: 5 tzg/ml insu- 
lin (lane I); 0.01% FBS (lane 2); 0.1% FBS (lane 3); 1% FBS (lane 
4); 10% FBS (lane 5); 5 tLg/ml insulin in DME medium alone (lane 
6); 5 ~g/ml insulin in DME:F12 medium (lane 7); same sample 
as in lane 7, digested with purified bacterial eollagenase (1 mg/mi) 
at 37"C for 30 rain prior to eleetropboresis (lane 8); intact growth 
cartilage from neonatal rat distal femur maintained as anexplanted 
organ culture for 3 d (lane 9); 5 ttg/ml insulin and 50 ng/ml rat 
growth hormone (lane 10); 5 tzg/ml insulin, 50 #g/ml rat growth 
hormone, and 1 ng/ml L-thyroxine (lane 11); 5 ~tg/mi insulin, 50 
ng/ml rat growth hormone, and 100ng/ml L-thyroxine (lane 12). 
binant human IGF-I (20 ng/ml), IGF-II (20 ng/ml), or a 
lower dose of insulin (100 ng/ml) did not result in a delete- 
rious effect on cell survival, but ehondrocyte hypertrophy did 
not occur (data not shown). Attempts to substitute rat growth 
hormone (50 ng/ml), recombinant porcine TGF-~ (10 ng/ 
ml), purified bovine BMP-3 (10 ng/ml), recombinant human 
BMP-4 (10 ng/ml), and recombinant human OP-1 (BMP-7) 
(10 ng/ml) for insulin uniformly resulted in failure of cells 
to survive and proliferate within the first few days of the cul- 
ture period. 
Of interest is the observation that addition of 10 ng/ml of 
BMP-4 or BMP-7 to insulin-containing DME:F12 medium 
effected a striking increase in pellet size by day 21 (data not 
shown). Histologic examination revealed large areas of hy- 
pertrophic cells in the center of the pellet, indicating an am- 
plified anabolic response to BMP-4 and BMP-7 without inhi- 
Alkaline Phoephatlme Activity Over 21 Day Culture Period 
t 20. 
10" 
Figure 4. Expression of genes 
encoding type II collagen and 
type X collagen by chondro- 
cytes in pellet cultures main- 
tained for 21 days in the pres- 
ence of 0.01% to 10% FBS or 
insulin (5 #g/ml). 
0 ' ~  
Dey7 Day14 Day21 
Figure 6. Alkaline phosphatase activity at 7, 14, and 21 d in cultures 
maintained in chemically defined DME:FI2 medium supplemented 
with insulin (5 ~tg/ml). Differences between means for serum- and 
insulin-treated cultures were significant both at Day 14 (p < 0.001) 
and Day 21 (p < 0.001). 
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Alkaline Phosphatau  Act iv i ty  In Serum-Enriched Media 
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Figure 7.. Alkaline phosphatase activity at day 21 in cultures main- 
tained in DME:F12 media in the presence of 0.01 to 10% FBS or 
insulin (5 #g/ml). One-way ANOVA confirmed a significant effect 
of serum concentration on resulting alkaline phosphatase activity 
(p < 0.001). The insulin-treated cultures demonstrated significantly 
less alkaline phosphatase activity at day 21 than all other serum- 
treated specimens (p < 0.001). 
bition of terminal differentiation. As reported previously for 
serum-containing media (2), addition of TGF-/$1 (10 ng/ml) 
to insulin-containing media reduced the final size of the pel- 
let compared to controls, and also inhibited terminal differ- 
entiation of these cells. 
Discuss ion  
The organization of proliferating chondrocytes into longi- 
tudinal columns is a critical event during the development 
and growth of the skeleton. During the early stages of em- 
bryogenesis, the condensation of mesenchyme into cartilage 
Figure 8. (A) Chondrocyte morphology at day 21 in pellet cultures 
in which rat growth hormone (50 ng/ml) was added to chemically 
defined media containing insulin (5/zg/ml). Lack of cellular hyper- 
trophy and random orientation of he cells were noted. (B) Higher 
power photomicrograph of ellet cultures in which L-thyroxine (100 
ng/ml) has been added to chemically defined media containing both 
growth hormone (50 ng/ml) and insulin (5/~g/ml). The chondro- 
cytes have organized into columns of flattened cells resembling the 
proliferative zone of the growth plate in vivo. 
Thymxlne Stimulates Alkaline Phosphatalle Actlvlty In Chemically-Defined Medla 
| 
l 
F 
"t 
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Figure 9. Alkaline phosphatase activity at da 21 in cultures treated 
with thyroxine in the presence of growth hormone (50 ng/ml) and 
insulin (5/~g/ml). One-way ANOVA confirmed a significant effect 
of thyroxine concentration on resulting alkaline phosphatase activ- 
ity (p < 0.001). 
is followed by organization ofthis tissue into longitudinal r- 
rays of flattened, proliferative cells which impose pattern o  
subsequent limb and vertebral growth. This columnar archi- 
tecture is maintained throughout the developmental period 
and into early adulthood as the growth plates of the vertebrae 
and long bones. Disorganization of these columns is often 
seen in association with disorders of longitudinal bone 
growth (18, 22). 
Our results indicate that factors present in serum are re- 
sponsible for organization of this columnar architecture in
growing cartilage. The observation that optimal serum con- 
centrations of 0.1 to 0.01% have a profound effect on tissue 
organization suggests that the responsible serum factors 
must be active at very low concentrations, and therefore may 
be hormonal in nature. 
It is well known from the early studies of Evans and col- 
leagues that growth hormone is of paramount importance in  
the regulation of skeletal growth and maturation (15), there- 
fore we initially examined the effect of this anterior pituitary 
hormone on terminal chondrocyte differentiation. The re- 
suits of these experiments revealed that growth hormone 
alone has no pronounced effects on the longitudinal column 
architecture ofchondrocytes. Because thyroxine is known to 
have synergistic effects with growth hormone during endo- 
chondral ossification (20, 21) and has recently been shown 
to stimulate type X collagen synthesis and alkaline phospha- 
tase activity in suspension cultures of chick embryo chon- 
drocytes (7, 19), we investigated the effect of thyroxine sup- 
plementation f chemically defined media containing rowth 
hormone and insulin. Thyroxine supplementation not only 
recreated the serum-induced organization of chondrocytes 
into columns, but also produced attendant increases in both 
type X collagen synthesis and alkaline phosphatase activity 
to levels equivalent to those achieved with optimal serum. 
These results strongly suggest that thyroxine is the serum 
factor esponsible for facilitating the cellular and molecular 
events of terminal chondrocyte differentiation observed in 
optimal serum cultures, including morphogenesis of colum- 
nar cartilage. This observation also illuminates potential 
pathophysiological mechanisms involved the well-recognized 
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Figure 10 Morphologic ap- 
pearanea ofchondroeytes main- 
tained in pellet cnimres for 21 
days in various formulations 
of chemically defined media 
supplemented with insulin 
(5/~g/ml). (A) Fitton-Jackson 
modified BGJb medium; (B) 
CMRL 1066 medium; (C) 
DME; (D) DME:FI2 medium 
(l:l); (E) MEM; (F) Ham's 
F12 medium. Bar, 100 #m. 
clinical disorder of slipped capital femoral epiphysis which 
is common among children with hypothyroidism (26). 
The mechanism by which chondrocytes form these longi- 
tudinal columns of cells is not known, but is likely to be re- 
lated to interactions between the chondrocyte cytoskeleton 
and the extracellular matrix proteins urrounding the cell. 
This mechanism could conceivably involve integrins, since 
it has recently been shown that the B1 integrin mediates the 
attachment ofchondrocytes totype I and type II collagen (9). 
Future investigations will likely focus on the specific role 
Alkaline Phosphatue Activity In Serum-Free Media 
5~ 
E 
[ 
Figure 11. Expression of genes 
encoding type II collagen and 
type X collagen by chondro- 
cytes in pellet cultures main- 
tained for 21 d in various 
formulations of chemically 
defined media containing in- 
sulin (5 #g/ml). 
Figure 12. Alkaline phosphatase activity at da  21 in cultures main- 
tained for 21 d in various formulations of chemically defined media 
containing insulin (5 #g/ml). One-way ANOVA confirmed a signifi- 
cant effect ofmedia formulation o  resulting alkaline phosphatase 
activity (p < 0.001). Both DME and DME:FI2 media yielded sig- 
nificantly higher alkaline phosphatase activity than other formula- 
tions (p < 0.01), but were not significantly different from each other 
(p > 0.05). 
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thyroxine and the DNA-binding thyroid hormone receptor 
play in regulating type X collagen synthesis, alkaline phos- 
phatase activity, and the morphogenesis of columnar ear- 
tilage. 
It was of interest to observe the formation of a peri- 
chondrium-like layer around the exterior of the cell pellet in 
cultures maintained in serum concentrations greater than 
0.1%. This perichondrial structure may be related to the 
presence of cell adhesion proteins in the serum. This layer 
is not necessary for continued growth of the aggregate as 
elimination of serum effected even larger increases in pellet 
size despite the absence of this periehondrium. 
Current data also demonstrate that the events of terminal 
chondrocyte differentiation are uncoupled when serum is re- 
moved from the culture media. In the presence of insulin 
alone, chondrocytes maintain the ability to increase their in- 
tracellular volume, indicating that chondrocyte hypertrophy 
is a default pathway that does not require exogenous signals. 
The long lag period (21 days) between the beginning of insu- 
lin treatment and the onset of hypertrophy suggests that the 
role of insulin in regulating chondrocyte hypertrophy is per- 
haps permissive rather than instructive. All of the informa- 
tion necessary for cellular enlargement to occur is resident 
in the resting cells. 
At the high doses used in these experiments, insulin has 
been reported to bind to both the insulin receptor and the 
IGF-I receptor, suggesting that both pathways might require 
activation to permit chondrocyte hypertrophy to occur. In 
this regard, it is noteworthy that when the insulin concentra- 
tion was reduced or replaced with IGF-I or IGF-H, chon- 
drocyte viability was maintained, but there was no cellular 
hypertrophy. 
The modest elevation in gene expression for type X colla- 
gen combined with the noticeable increase in type X colla- 
gen protein as the serum concentration decreased suggests 
the possibility that 0.01 to 0.1% serum represents the opti- 
mum culture conditions for chondrocyte differentiation. Ai- 
though we have not directly evaluated transcriptional or 
translational regulation of the type X collagen gene in these 
studies, it is possible that specific factors present in serum 
may inhibit transcription or translation of this gene when 
present in larger concentrations at the higher serum levels. 
Received for publication 22 November 1993 and in revised form 23 May 
1994. 
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